DM, CV Disease and Lipid Management in Patients Who Are High Risk

CHF in 2019 - The New Frontier

Wednesday, April 24
10:05 AM - 10:30 AM
Location: Convention Center 502 B

Learning Objectives:

Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE

Medical Director and Principal Investigator
Metabolic Institute of America, Inc.

Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE is an endocrinologist in private practice, Medical Director & Principal Investigator of the Metabolic Institute of America. A Master of the American College of Endocrinology, Fellow American Society of Preventive Cardiology, of the American College of Physicians and The National lipid Association He is Board Member American Association for Preventive Cardiology, Chair of the AACE Lipid & CV Health Disease network. Past president of the American College of Endocrinology, AACE & the Pacific Lipid Association, Chair Annual World Congress on Insulin Resistance, DM & CVD, the Heart in Diabetes and the International Lipid Forum. He published over 110 original research, review papers, editorials and books’ chapters, a recent Book “Clinical Management of Cardiovascular Risk in Diabetes and Obesity”; and is also an author of the AACE Diabetes and Lipids Guidelines

Presentation(s):

Send Email for Yehuda Handelsman


Assets

CHF in 2019 - The New Frontier

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for CHF in 2019 - The New Frontier